Company Filing History:
Years Active: 2017-2019
Title: Rashmikant Kachhiya: Innovator in Diabetes Treatment
Introduction
Rashmikant Kachhiya is a notable inventor based in Gujarat, India. He has made significant contributions to the field of diabetes treatment through his innovative research and development. With a total of 3 patents to his name, Kachhiya is recognized for his work in creating synergistic compositions that aid in managing diabetes.
Latest Patents
Kachhiya's latest patents focus on synergistic compositions that combine one or more statins, dipeptidyl peptidase IV (DPP IV) inhibitors, and biguanide antihyperglycaemic agents with a PPAR agonist. These compositions are specifically designed for the treatment of non-insulin dependent diabetes (NIDDM) or Type 2 diabetes, along with conditions associated with diabetes mellitus. The inventions also detail the preparation of these compositions and novel salts of the PPAR agonist, along with processes for their preparation and use.
Career Highlights
Rashmikant Kachhiya is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing diabetes treatment options. Kachhiya's innovative approach and dedication to research have positioned him as a key figure in the field.
Collaborations
Kachhiya has collaborated with notable colleagues such as Mukul R Jain and Suresh Giri. These collaborations have further enhanced the scope and impact of his research in diabetes treatment.
Conclusion
Rashmikant Kachhiya's contributions to diabetes treatment through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the management of diabetes, making a significant impact in the field.